全文获取类型
收费全文 | 124624篇 |
免费 | 8242篇 |
国内免费 | 454篇 |
专业分类
耳鼻咽喉 | 1630篇 |
儿科学 | 3295篇 |
妇产科学 | 2070篇 |
基础医学 | 15964篇 |
口腔科学 | 2371篇 |
临床医学 | 12551篇 |
内科学 | 26354篇 |
皮肤病学 | 1915篇 |
神经病学 | 11970篇 |
特种医学 | 4271篇 |
外国民族医学 | 4篇 |
外科学 | 18017篇 |
综合类 | 1889篇 |
现状与发展 | 1篇 |
一般理论 | 168篇 |
预防医学 | 11112篇 |
眼科学 | 2913篇 |
药学 | 8720篇 |
2篇 | |
中国医学 | 173篇 |
肿瘤学 | 7930篇 |
出版年
2023年 | 511篇 |
2022年 | 831篇 |
2021年 | 2073篇 |
2020年 | 1227篇 |
2019年 | 2014篇 |
2018年 | 2319篇 |
2017年 | 1786篇 |
2016年 | 1957篇 |
2015年 | 2412篇 |
2014年 | 3439篇 |
2013年 | 5336篇 |
2012年 | 7763篇 |
2011年 | 8288篇 |
2010年 | 4689篇 |
2009年 | 4512篇 |
2008年 | 7967篇 |
2007年 | 8520篇 |
2006年 | 8350篇 |
2005年 | 8642篇 |
2004年 | 8175篇 |
2003年 | 8001篇 |
2002年 | 7574篇 |
2001年 | 1180篇 |
2000年 | 930篇 |
1999年 | 1230篇 |
1998年 | 1704篇 |
1997年 | 1424篇 |
1996年 | 1162篇 |
1995年 | 1149篇 |
1994年 | 942篇 |
1993年 | 960篇 |
1992年 | 754篇 |
1991年 | 705篇 |
1990年 | 670篇 |
1989年 | 623篇 |
1988年 | 576篇 |
1987年 | 543篇 |
1986年 | 544篇 |
1985年 | 662篇 |
1984年 | 832篇 |
1983年 | 830篇 |
1982年 | 1162篇 |
1981年 | 1054篇 |
1980年 | 950篇 |
1979年 | 464篇 |
1978年 | 575篇 |
1977年 | 547篇 |
1976年 | 449篇 |
1975年 | 408篇 |
1974年 | 365篇 |
排序方式: 共有10000条查询结果,搜索用时 9 毫秒
101.
102.
103.
Terry Joe Sprinkle Julia F. Agee Russell B. Tippins C. Richard Chamberlain Guy B. Faguet George H. DeVries 《Brain research》1987,426(2):349-357
Monoclonal antibodies against human and bovine 2′:3′-cyclic nucleotide 3′-phosphodiesterase (CNPase) were generated by fusing FOX-NY myeloma cells with spleen cells from RBF/Dn mice previously immunized with the purified brain antigens. The enzyme isolated from bovine brain was quite basic, with an isoelectric point of 9.71 and both the bovine and human enzymes consisted of a closely spaced doublet at approximately 44 and 46 kDa on SDS-PAGE. Six monoclonals were identified as strongly recognizing the enzyme on both ELISA plates and on immunoblots of whole brain protein. Four monoclonals very weakly cross-reacted with guinea pig myelin basic protein. In contrast with two previous reports, some of our monoclonal antibodies did immunostain 2 or 3 protein bands in peripheral nerve, two bands closely corresponding to those immunostained in central nervous system (CNS) myelin, the Wolfgram protein fraction and in acetone powders of whole brain. Each of the 6 monoclonals reacting strongly on immunoblots recognized the enzyme in from 2 to 5 of the species examined (human, bovine, rat, mouse and rabbit). In addition, all 6 monoclonals that immunostained the enzyme in whole brain, myelin and Wolfgram protein immunoblots recognized both CNP1 (44 kDa) and CNP2 (46 kDa). The two closely spaced protein bands observed on SDS-PAGE and previously stained on immunoblots of CNS CNPase using polyvalent rabbit anti-bovine CNPase antisera, and now different monoclonal antibodies, appear to be immunologically related and to contain highly conserved sequences. 相似文献
104.
105.
Vitamin E biokinetics, oxidative stress and cigarette smoking. 总被引:2,自引:0,他引:2
Vitamin E is comprised of four tocopherols and four tocotrienols, and functions as a lipophilic chain-breaking antioxidant that prevents lipid peroxidation. Although it is well recognized that cigarette smoke is source of oxidative stress, relatively little is known regarding how oxidative stress alters vitamin E utilization in humans. Therefore, this review will highlight the recent knowledge regarding how cigarette smoking alters vitamin E (as alpha- and gamma-tocopherols) utilization in humans. Specifically, we will discuss the mechanisms by which cigarette smoking increases the turnover of plasma vitamin E, decreases the P450-mediated metabolism of vitamin E, and increases the nitration of gamma-tocopherol to result in the formation of 5-nitro-gamma-tocopherol. In addition, the interrelationship between oxidative stress and vitamin C will also be emphasized as it relates to vitamin E utilization. 相似文献
106.
107.
Donald B. Penzien PhD ; Frank Andrasik PhD ; Brian M. Freidenberg PhD ; Timothy T. Houle PhD ; Alvin E. Lake III PhD; Gay L. Lipchik PhD ; Kenneth A. Holroyd PhD ; Richard B. Lipton MD ; Douglas C. McCrory MD ; Justin M. Nash PhD ; Robert A. Nicholson PhD ; Scott W. Powers PhD ABPP ; Jeanetta C. Rains PhD ; David A. Wittrock PhD 《Headache》2005,45(S2):S110-S132
Guidelines for design of clinical trials evaluating behavioral headache treatments were developed to facilitate production of quality research evaluating behavioral therapies for management of primary headache disorders. These guidelines were produced by a Workgroup of headache researchers under auspices of the American Headache Society. The guidelines are complementary to and modeled after guidelines for pharmacological trials published by the International Headache Society, but they address methodologic considerations unique to behavioral and other nonpharmacological treatments. Explicit guidelines for evaluating behavioral headache therapies are needed as the optimal methodology for behavioral (and other nonpharmacologic) trials necessarily differs from the preferred methodology for drug trials. In addition, trials comparing and integrating drug and behavioral therapies present methodological challenges not addressed by guidelines for pharmacologic research. These guidelines address patient selection, trial design for behavioral treatments and for comparisons across multiple treatment modalities (eg, behavioral vs pharmacologic), evaluation of results, and research ethics. Although developed specifically for behavioral therapies, the guidelines may apply to the design of clinical trials evaluating many forms of nonpharmacologic therapies for headache. 相似文献
108.
Dean McMillan Richard P. Hastings Jon Coldwell 《Journal of Applied Research in Intellectual Disabilities》2004,17(4):255-265
Background There is a high rate of physical violence in populations with intellectual disabilities, and this has been linked to problems for the victim, the assailant, members of staff and services. Despite the clinical significance of this behaviour, few studies have assessed methods of predicting its occurrence. The present study examined clinical and actuarial methods of predicting violence in a forensic intellectual disability hospital. Methods The sample for the study consisted of people resident in the hospital during a 1‐year period (n = 124). Clinical prediction used a risk rating made by members of the person's clinical team, whereas actuarial prediction used the number of violent incidents in the 6‐months before the date of the clinical risk assessment. Computerized hospital records of violence in the 6 months after the assessment were used to examine the predictive accuracy of the two methods. Results The clinical method produced an area under the curve of 0.74 (95% CI: 0.65–0.83) in a receiver–operating characteristic curve analysis. The value for the actuarial method was 0.77 (95% CI: 0.69–0.86). Both methods performed at levels significantly above chance, but no one method was found to be superior to the other. Conclusions These findings suggest that it is possible to predict who is at risk of violence in forensic populations with intellectual disabilities. Here, the authors discuss the clinical implications of these findings and the clinical application of risk prediction within clinical services. 相似文献
109.
The second part of this review addresses the treatment and prognosis of the vasculitides Wegener's granulomatosis, microscopic
polyangiitis, Churg–Strauss syndrome and polyarteritis nodosa. Treatment regimens consist of an initial remission phase with
aggressive immunosuppression, followed by a more prolonged maintenance phase using less toxic agents and doses. This review
focuses on the initial treatment of fulminant vasculitis, the mainstay of which remains immunosuppression with steroids and
cyclophosphamide. For Wegener's granulomatosis and microscopic polyangiitis plasma exchange can be considered for first-line
therapy in patients with acute renal failure and/or pulmonary haemorrhage. Refractory disease is rare and is usually due to
inadequate treatment. The vasculitides provide a particular challenge for the critical care team. Particular aspects of major
organ support related to these conditions are discussed. Effective treatment has revolutionized the prognosis of these conditions.
However, mortality is still approximately 50% for those requiring admission to intensive care unit. Furthermore, there is
a high morbidity associated with both the diseases themselves and the treatment. 相似文献
110.